Connective tissue growth factor induces tubular epithelial to mesenchymal transition through the activation of canonical Wnt signaling in vitro

References

• Cho MH. Renal fibrosis. Korean J Pediatr. 2010;53:735–740
   PubMedGoogle Scholar
• Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;12(2):212–222
   Google Scholar
• Takigawa M. CTGF/Hcs24 as a multifunctional growth factor for fibroblasts, chondrocytes and vascular endothelial cells. Drug News Perspect. 2003;16:11–21
   PubMed Web of Science ®Google Scholar
• Phanish MK, Winn SK, Dockrell ME. Connective tissue growth factor-(CTGF, CCN2)—A marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol. 2010;114(3):e83–e92
   PubMed Web of Science ®Google Scholar
• Chen XM, Qi W, Pollock CA. CTGF and chronic kidney fibrosis. Front Biosci. 2009;1:132–141
   Google Scholar
• Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: Implications for diabetic renal disease. J Am Soc Nephrol. 2006;17:2484–2494
   PubMed Web of Science ®Google Scholar
• Liu XC, Liu BC, Zhang XL, Li MX, Zhang JD. Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. Clin Chim Acta. 2007;382(1–2):89–94
   PubMedGoogle Scholar
• Wahab NA, Mason RM. A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. Nephron Exp Nephrol. 2006;104(4):e129–e134
   Google Scholar
• Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int. 2002;26(5):463–476
   PubMed Web of Science ®Google Scholar
• Zhou D, Tan RJ, Zhou L, Li Y, Liu Y. Kidney tubular β-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep. 2013;3:1878
   PubMed Web of Science ®Google Scholar
• Xiao L, Wang M, Yang S, Liu F, Sun L. A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy. Biomed Res Int. 2013;2013:987064
   PubMed Web of Science ®Google Scholar
• Kim MK, Maeng YI, Sung WJ, et al. The differential expression of TGF-β1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: An immunohistochemical study. Int J Clin Exp Pathol. 2013;6(9):1747–1758
   PubMedGoogle Scholar
• Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development. 2004;131(9):2137–2147
   PubMedGoogle Scholar
• Rooney B, O’Donovan H, Gaffney A, et al. CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy. FEBS Lett. 2011;585:531–538
   PubMed Web of Science ®Google Scholar
• Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27:195–207
   PubMed Web of Science ®Google Scholar
• Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 2004;15(1):1–12
   PubMed Web of Science ®Google Scholar
• Zuehlke J, Ebenau A, Krueger B, Goppelt-Struebe M. Vectorial secretion of CTGF as a cell-type specific response to LPA and TGF-βin human tubular epithelial cells. Cell Commun Signal. 2012;10(1):25
   PubMedGoogle Scholar
• Boor P, Floege J. Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol. 2011;38(7):441–450
   PubMedGoogle Scholar
• Wang S, DeNichilo M, Brubaker C, Hirschberg R. Connective tissue growth factor in interstitial injury of diabetic nephropathy. Kidney Int. 2001;60:96–105
   PubMed Web of Science ®Google Scholar
• Wing MR, Ramezani A, Gill HS, Devaney JM, Raj DS. Epigenetics of progression of chronic kidney disease: Fact or fantasy? Semin Nephrol. 2013;33(4):363–374
   PubMed Web of Science ®Google Scholar
• Gupta S, Clarkson MR, Duggan J, Brady HR. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 2000;58:1389–1399
   PubMed Web of Science ®Google Scholar
• Liu BC, Zhang JD, Zhang XL, Wu GQ, Li MX. Role of connective tissue growth factor (CTGF) module 4 in regulating epithelial mesenchymal transition (EMT) in HK-2 cells. Clin Chim Acta. 2006;373(1–2):144–150
   PubMedGoogle Scholar
• Wu G, Huang H, Garcia Abreu J, He X. Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS One. 2009;4:e4926
   PubMed Web of Science ®Google Scholar
• Cselenyi CS, Jernigan KK, Tahinci E, Thorne CA, Lee LA, Lee E. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3’s phosphorylation of beta-catenin. Proc Natl Acad Sci USA. 2008;105:8032–8037
   PubMed Web of Science ®Google Scholar
• Piao S, Lee SH, Kim H, Yum S, Stamos JL, Xu Y, et al. Direct inhibition of GSK3β by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling. PLoS One. 2008;3:e4046
   PubMed Web of Science ®Google Scholar
• Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev. 2000;11:273–282
   PubMed Web of Science ®Google Scholar
• Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signaling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol. 2001;3:683–686
   PubMed Web of Science ®Google Scholar